Analysis of cervical lesion screening of rural women in Hebei Province from 2015 to 2017
-
摘要:
目的 分析2015―2017年河北省农村妇女宫颈病变筛查项目的数据,评价项目开展实施情况。 方法 对2015―2017年河北省12个地区下属县、区及1个直管县共66个县、区35~64岁已婚农村妇女进行妇科检查及宫颈病变筛查,细胞学检查阳性者行阴道镜检查,阴道镜检查结果怀疑宫颈病变的多点组织活检行病理学检查。收集各监测点上报数据,应用SPSS 22.0软件进行统计学分析。 结果 2015―2017年河北省运用贝塞斯达系统(the Bethesda system, TBS)分类的描述性报告的比例分别为95.26%、95.23%和96.66%。阴道镜异常检出率从2015年的19.62%(2 040例)下降到2017年的17.45%(1 968例)(χ2 =16.84, P<0.001),组织病理学异常检出率由2015年的26.87%(588例)上升至2017年的38.41%(822例)(χ2 =65.56, P<0.001)。宫颈癌前病变检出率由2015年的75.27/10万逐年提高到2017年105.91/10万(χ2 =23.86, P<0.001)。宫颈浸润癌检出率由2015年的17.28/10万上升至2017年的21.07/10万(χ2 =2.77, P=0.251),早期诊断率由2015年84.94%逐年增至2017年的86.80%(χ2 =0.57, P=0.751)。 结论 河北省宫颈癌筛查项目达到一定的筛查目的及效果,尤其是癌前病变筛查方面,但是在阴道镜和组织病理学检查方面仍需优化,技术有待提高。 Abstract:Objective To analyze the data of rural women's cervical disease screening project in Hebei Province from 2015-2017, and to evaluate the implementation condition of the project. Methods Gynecological examination and cervical cytology examination were conducted on married women aged 35-64 years in rural regions of 66 prefectures/counties during 2015-2017. Colposcopy was performed among the examinees with abnormal cervical cytology and multiple biopsy was subsequently carried out among the examinees with suspicious cervical lesions. We collected the data onto each monitoring point. SPSS 22.0 system software has used for statistical analysis. Results From 2015 to 2017, the proportion of descriptive reports using the Bethesda system (TBS) classification in Hebei Province was 95.26%, 95.23% and 96.66%, respectively. The abnormal detection rate of colposcopy discreased from 19.62% (n=2 040) in 2015 to 17.45% (n=1 968) in 2017 (χ2 =16.84, P < 0.001). The abnormality rate of histopathology increased from 26.87% (n=588) in 2015 to 38.41% (n=822) in 2017 (χ2 =65.56, P < 0.001). The detection rate of cervical precancerous lesions increased from 75.27/100 000 in 2015 to 105.91/100 000 in 2017(χ2 =23.86, P < 0.001). The detection rate of cervical invasive cancer increased from 17.28/100 000 in 2015 to 21.07/100 000 in 2017 (χ2 =2.77, P=0.251). The early diagnosis rate increased from 84.94% in 2015 to 86.80% in 2017(χ2 =0.57, P=0.751). Conclusions The cervical cancer screening project of Hebei Province has achieved certain screening effect, especially in the screening of precancerous lesions. However, the quality of colposcope and histopathology need to be optimized. -
Key words:
- Rural women /
- Cervical lesion /
- Screening /
- Hebei Province
-
表 1 2015―2017河北省农村妇女宫颈癌初筛方法筛查结果
Table 1. Screening results of primary cervical cancer screening methods for rural women in Hebei Province from 2015-2017
方法 2015年(n=358 723) 2016年(n=367 114) 2017年(n=370 129) 初筛人数(例) 阳性人数(例) 阳性率(%) 初筛人数(例) 阳性人数(例) 阳性率(%) 初筛人数(例) 阳性人数(例) 阳性率(%) 宫颈细胞学检查 356 994 10 031 2.81 366 232 8 372 2.29 367 096 10 979 3.00 巴氏涂片检查 15 287 114 0.75 16 640 151 0.91 9 340 11 0.12 TCT 341 707 9 917 2.90 349 592 8 221 2.35 357 756 10 968 3.07 VIA/VILI 1 468 46 3.13 377 71 18.83 359 50 13.93 表 2 2015―2017年河北省初步筛查、阴道镜及组织病理学阳性结果情况
Table 2. Positive results of preliminary screening, colposcopy and histopathology in Hebei Province from 2015 to 2017
年份 初筛 阴道镜 病理活检 阳性例数(例) 阳性率(%) 检查人数(例) 异常人数(例) 异常率(%) 异常人数(例) 异常率(%) 2015 10 077 2.81 10 398 2 040 19.62 588 26.87 2016 8 443 2.30 8 717 1 536 17.62 640 38.55 2017 11 029 2.98 11 276 1 968 17.45 822 38.41 表 3 2015―2017年河北省农村妇女子宫颈癌前病变、宫颈癌检出和早期诊断情况
Table 3. Comparison of detection rate and early diagnosis rate of cervial precancerous lesions and cercival cancer among rural women in Hebei Province from 2015 to 2017
分类 2015年(n=358 723) 2016年(n=367 114) 2017年(n=370 129) χ2值 P值 检出例数(例) 检出率(/105) 检出例数(例) 检出率(/105) 检出例数(例) 检出率(/105) 宫颈浸润癌及癌前病变 332 89.76 348 94.79 470 126.98 26.02 <0.001 宫颈癌前病变 270 75.27 289 78.72 392 105.91 23.86 <0.001 宫颈浸润癌 62 17.28 59 16.07 78 21.07 2.77 0.251 早期诊断(%) 282 84.94 300 86.20 408 86.80 0.57 0.751 表 4 2015―2017年河北省农村妇女不同程度宫颈病变检出情况
Table 4. Detection of cervical lesions of different degrees in rural women in Hebei Province from 2015 to 2017
分类 2015年(n=358 723) 2016年(n=367 114) 2017年(n=370 129) χ2值 P值 检出例数(例) 检出率(/105) 检出例数(例) 检出率(/105) 检出例数(例) 检出率(/105) 低级别病变 253 70.53 283 77.09 352 95.10 14.65 0.001 高级别病变 255 71.09 286 77.91 381 102.94 24.53 <0.001 原位腺癌 15 4.18 9 2.45 11 2.97 1.79 0.409 微小浸润癌 12 3.35 11 3.00 16 4.32 0.98 0.613 浸润癌 50 13.94 48 13.08 62 16.75 1.87 0.393 -
[1] Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysi [J]. Lancet Glob Health, 2020, 8: e191-203. DOI: 10.1016/s2214-109x(19)30482-6. [2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132. DOI: 10.3322/caac.21338. [3] 郎景和. 子宫颈上皮内瘤变的诊断与治疗[J]. 中华妇产科杂志, 2001, 36(5): 261-263. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHFC200105000.htmLang JH. Problems in cennection with diagnosis and treatment of cervical lesion [J]. Chin J Obstetr Gynecol, 2001, 36(5): 261-263. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHFC200105000.htm [4] Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology [J]. JAMA, 2002, 287(16): 2114-2119. DOI: 10.1001/jama.287.16.2114. [5] Watson M, Benard V, King J, et al. National assessment of HPV and Pap tests: Changes in cervical cancer screening, National Health Interview Survey [J]. Prev Med, 2017, 100: 243-247. DOI: 10.1016/j.ypmed.2017.05.004. [6] Swanson M, Ibrahim S, Blat C, et al. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study [J]. BMC Womens Heal, 2018, 18(1): 116. DOI: 10.1186/s12905-018-0586-0. [7] Musa J, Achenbach CJ, O'Dwyer LC, et al. Effect of cervical cancer education and provider recommendation for screening on screening rates: a systematic review and meta-analysis [J]. PLoS One, 2017, 12(9): e0183924. DOI: 10.1371/journal.pone.0183924. [8] 张韶凯, 罗喜平, 李志芳, 等. 人乳头瘤病毒分型检测在宫颈癌前病变和宫颈癌筛查中的应用价值[J]. 中华肿瘤杂志, 2020, 42(3): 252-256. DOI: 10.3760/cma.J.cn112152-20190603-00346.Zhang SK, Luo XP, Li ZF, et al. Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening [J]. Chin J Oncol, 2020, 42(3): 252-256. DOI: 10.3760/cma.j.cn112152-20190603-00346. [9] 高丽丽, 沈洁, 张月, 等. 2008-2014年北京市子宫颈癌筛查数据分析[J]. 中国妇产科临床杂志, 2017, 18(2): 124-127. DOI: 10.13390/j.issn.1672-1861.2017.02.009.Gao LL, Shen J, Zhang Y, et al. Data analysis of cervical cancer screening in Beijing from 2008 to 2014 [J]. Chin J Clin Obstet Gynecol, 2017, 18(2): 124-127. DOI: 10.13390/j.issn.1672-1861.2017.02.009. [10] 商广洁, 董燕, 张玉萍, 等. 2012-2017年山西省农村妇女宫颈癌筛查结果分析[J]. 中国肿瘤, 2020, 29(6): 425-429. DOI: 10.11735/j.issn.1004-0242.2020.06.A004.Shang GJ, Dong Y, Zhang YP, et al. Analysis of cervical cancer screening results of rural women in Shangxi Province from 2012 to 2017 [J]. China Cancer, 2020, 29(6): 425-429. DOI: 10.11735/j.issn.1004-0242.2020.06.A004. [11] 杨丽, 李伟栋, 邹兴文, 等. 广州市2009-2017年农村妇女宫颈癌筛查结果分析[J]. 中华肿瘤防治杂志, 2018, 25(17): 1201-1204, 1210. DOI: 10.16073/j.cnki.cjcpt.2018.17.001.Yang L, Li WD, Zou XW, et al. . Analysis of the cervical cancer screening programme among women in rural areas of Guangzhou [J]. Chin J Cancer Prev Treat, 2018, 25(17): 1201-1204, 1210. DOI: 10.16073/j.cnki.cjcpt.2018.17.001. [12] 张继国, 张小虎, 袁盛丽, 等. 湖北省襄阳市30~64岁妇女宫颈癌和乳腺癌筛查结果分析[J]. 肿瘤防治研究, 2020, 47(9): 694-701. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLFY202009010.htmZhang JG, Zhang XH, Yuan SL, et al. Screening results of cervical and breast cancers in women aged 30-64 years in Xiangyang city, Hubei Province[J]. Cancer Res Prev Treat, 2020, 47(9): 694-701. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLFY202009010.htm [13] 罗晓敏, 宋莉, 吴久玲, 等. 中国农村妇女宫颈癌检查项目2012和2013年上报数据结果分析[J]. 中华预防医学杂志, 2016, 50(4): 346-350. DOI: 10.3760/cma.j.issn.0253-9624.2016.04.012.Luo XM, Song L, Wu JL, et al. Analysis of the reported data of national rural cervical cancer screening project from 2012 to 2013, China [J]. Chin J Prev Med, 2016, 50(4): 346-350. DOI: 10.3760/cma.j.issn.0253-9624.2016.04.012.